C3b antibodies and methods for the prevention and treatment of complementassociated disorders
Details for Australian Patent Application No. 2008262048 (hide)
International Classifications
Event Publications
17 December 2009 PCT application entered the National Phase
PCT publication WO2008/154251 Priority application(s): WO2008/154251
3 February 2011 Amendment Made
The nature of the amendment is: Amend the priority details under INID (31) from 60/055,068 to 61/055,068
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008262056-Biphenylcarboxamide derivatives as hedgehog pathway modulators
2008262038-5-heteroaryl substituted indazoles as kinase inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser